SynCore Biotechnology Co., Ltd.(TW:4192)
NT$15.95-0.50 (-3.04%)
TW:4192
SynCore Biotechnology Co., Ltd. financials statements
NT$15.95
At close:-0.50 (-3.04%)
SynCore Biotechnology Co., Ltd. (4192) Ratios
SynCore Biotechnology Co., Ltd. Ratios
TW:4192's free cash flow for Q2 2026 was NT$-7.99M. For the 2026 fiscal year, TW:4192's free cash flow was increased by NT$0.00 and operating cash flow was NT$-7.99M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 21.37 | 11.77 | 14.63 | 1.87 | 1.86 |
| Quick Ratio | 20.41 | 11.32 | 14.48 | 1.77 | 1.82 |
| Cash Ratio | 15.62 | 9.29 | 12.47 | 1.44 | 1.45 |
| Solvency Ratio | -2.80 | -1.56 | -0.87 | -0.79 | -1.06 |
| Operating Cash Flow Ratio | -3.81 | -2.23 | -3.88 | -1.12 | -0.60 |
| Short-Term Operating Cash Flow Coverage | -260.77 | -253.82 | -508.48 | -3.46 | -1.91 |
| Net Current Asset Value | NT$ 205.19M | NT$ 237.35M | NT$ 289.25M | NT$ 160.60M | NT$ 329.19M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.03 | 0.01 | 0.16 | 0.15 |
| Debt-to-Equity Ratio | 0.01 | 0.03 | 0.01 | 0.29 | 0.28 |
| Debt-to-Capital Ratio | 0.01 | 0.03 | 0.01 | 0.22 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.08 | 1.06 | 1.75 | 1.86 |
| Debt Service Coverage Ratio | -92.55 | -72.18 | -18.74 | -2.33 | -3.31 |
| Interest Coverage Ratio | -272.81 | -191.25 | -58.04 | -82.08 | -224.35 |
| Debt to Market Cap | 0.17 | 0.00 | 0.00 | 0.02 | 0.03 |
| Interest Debt Per Share | 64.86 | 0.24 | 0.09 | 2.41 | 4.13 |
| Net Debt to EBITDA | 5.24 | 5.52 | 14.81 | 1.35 | 1.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 77.98% | 55.22% | 2.58% | 57.30% | 42.79% |
| EBIT Margin | -174.52% | -231.31% | -185.13% | -1175.47% | -6579.65% |
| EBITDA Margin | -109.51% | -153.41% | -87.77% | -922.78% | -5824.04% |
| Operating Profit Margin | -174.52% | -247.49% | -225.30% | -1175.47% | -6579.65% |
| Pretax Profit Margin | -169.19% | -232.60% | -189.01% | -1189.80% | -6608.98% |
| Net Profit Margin | -169.19% | -232.60% | -189.01% | -1189.80% | -6608.98% |
| Continuous Operations Profit Margin | -169.19% | -232.60% | -189.01% | -1189.80% | -6608.98% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 96.95% | 93.99% | 83.89% | 101.22% | 100.45% |
| Return on Assets (ROA) | -17.89% | -17.08% | -10.09% | -43.21% | -55.63% |
| Return on Equity (ROE) | -18.63% | -18.42% | -10.69% | -75.77% | -103.54% |
| Return on Capital Employed (ROCE) | -19.21% | -19.53% | -12.74% | -74.56% | -103.08% |
| Return on Invested Capital (ROIC) | -19.05% | -19.08% | -12.67% | -58.11% | -80.33% |
| Return on Tangible Assets | -20.92% | -19.82% | -11.66% | -49.89% | -61.79% |
| Earnings Yield | -5250.14% | -4.43% | -3.14% | -6.56% | -12.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.41 | 9.86 | 7.44 | 0.76 | 3.84 |
| Payables Turnover | 5.63 | 1.12 | 7.25 | 21.50 | 24.36 |
| Inventory Turnover | 0.62 | 1.04 | 6.28 | 0.39 | 0.23 |
| Fixed Asset Turnover | 9.00 | 2.46 | 4.36 | 1.07 | 0.62 |
| Asset Turnover | 0.11 | 0.07 | 0.05 | 0.04 | 0.01 |
| Working Capital Turnover Ratio | 0.12 | 0.09 | 0.09 | 0.06 | 0.02 |
| Cash Conversion Cycle | 611.05 | 62.75 | 56.84 | 1404.77 | 1659.82 |
| Days of Sales Outstanding | 82.83 | 37.01 | 49.03 | 479.47 | 95.10 |
| Days of Inventory Outstanding | 593.01 | 351.17 | 58.14 | 942.28 | 1579.71 |
| Days of Payables Outstanding | 64.79 | 325.43 | 50.33 | 16.98 | 14.99 |
| Operating Cycle | 675.84 | 388.17 | 107.17 | 1421.75 | 1674.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1095.23 | -1.40 | -2.57 | -6.82 | -7.45 |
| Free Cash Flow Per Share | -1106.83 | -1.41 | -2.59 | -6.85 | -7.51 |
| Dividend Paid and CapEx Coverage Ratio | -94.42 | -107.75 | -108.24 | -202.33 | -140.42 |
| Capital Expenditure Coverage Ratio | -94.42 | -107.75 | -108.24 | -202.33 | -140.42 |
| Operating Cash Flow Coverage Ratio | -18.28 | -6.17 | -38.97 | -2.92 | -1.83 |
| Operating Cash Flow to Sales Ratio | -1.42 | -2.11 | -4.08 | -13.22 | -33.13 |
| Free Cash Flow Yield | -4445.09% | -4.06% | -6.84% | -7.32% | -6.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.02 | -22.63 | -31.85 | -15.24 | -7.87 |
| Price-to-Sales (P/S) Ratio | 0.03 | 52.51 | 60.16 | 181.46 | 520.00 |
| Price-to-Book (P/B) Ratio | 0.00 | 4.16 | 3.40 | 11.56 | 8.15 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.02 | -24.66 | -14.61 | -13.66 | -15.59 |
| Price-to-Operating Cash Flow Ratio | -0.02 | -24.89 | -14.75 | -13.73 | -15.70 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -0.77 | 0.40 | 0.26 | -1.48 |
| Enterprise Value Multiple | 5.21 | -28.71 | -53.73 | -18.32 | -7.87 |
| Enterprise Value | -154.37M | 1.03B | 952.42M | 2.68B | 3.18B |
| EV to EBITDA | 5.21 | -28.71 | -53.73 | -18.32 | -7.87 |
| EV to Sales | -5.71 | 44.05 | 47.16 | 169.01 | 458.39 |
| EV to Free Cash Flow | 3.98 | -20.68 | -11.46 | -12.72 | -13.74 |
| EV to Operating Cash Flow | 4.03 | -20.88 | -11.56 | -12.79 | -13.84 |
| Tangible Book Value Per Share | 5961.20 | 7.13 | 9.55 | 7.42 | 14.30 |
| Shareholders’ Equity Per Share | 7017.94 | 8.38 | 11.14 | 8.10 | 14.36 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 772.66 | 0.66 | 0.63 | 0.52 | 0.22 |
| Net Income Per Share | -1307.29 | -1.54 | -1.19 | -6.14 | -14.87 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.97 | 1.01 | 1.02 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.91 | 1.21 | 0.19 | 9.92 | 60.96 |
| SG&A to Revenue | 1.62 | 1.81 | 2.08 | 2.73 | 5.57 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.84 | 0.91 | 2.16 | 1.11 | 0.50 |
Currency in TWD
